Published in Immunotechnology on March 01, 1997
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J (2003) 2.55
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs (2010) 1.83
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer. Biologics (2010) 1.26
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
On the training of young doctors in China. Quant Imaging Med Surg (2015) 1.17
Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies. Br J Cancer (2009) 1.09
CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction. Clin Exp Immunol (2010) 1.04
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Invest New Drugs (2010) 0.98
Using simple artificial intelligence methods for predicting amyloidogenesis in antibodies. BMC Bioinformatics (2010) 0.90
A view on EGFR-targeted therapies from the oncogene-addiction perspective. Front Pharmacol (2013) 0.88
New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN). Med Oncol (2012) 0.87
Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience. Cancer Biol Ther (2014) 0.86
A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis (2012) 0.85
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study. Onco Targets Ther (2014) 0.84
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Front Genet (2015) 0.81
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities. Onco Targets Ther (2013) 0.81
Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer. Int J Colorectal Dis (2015) 0.81
Therapeutic approaches to target cancer stem cells. Cancers (Basel) (2011) 0.80
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody. MAbs (2014) 0.78
Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences. Patholog Res Int (2015) 0.77
The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neck. Chemother Res Pract (2012) 0.77
Prediction and analysis of antibody amyloidogenesis from sequences. PLoS One (2013) 0.77
Validation of a flow cytometry based binding assay for evaluation of monoclonal antibody recognizing EGF receptor. Sci Pharm (2011) 0.76
Delineating the functional map of the interaction between nimotuzumab and the epidermal growth factor receptor. MAbs (2014) 0.76
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair. Onco Targets Ther (2015) 0.75
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer. Lung Cancer (Auckl) (2011) 0.75
Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells. Cytotechnology (2011) 0.75
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE(-/-) Mice: Association with Atheroprotection. Front Immunol (2017) 0.75
Stable expression of H1C2 monoclonal antibody in NS0 and CHO cells using pFUSE and UCOE expression system. Cytotechnology (2013) 0.75
Development and Validation of an Affinity Chromatography-Protein G Method for IgG Quantification. Int Sch Res Notices (2014) 0.75
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients. Front Pharmacol (2017) 0.75
Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun (1998) 3.92
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40
Visualization of gene expression in living adult Drosophila. Science (1996) 2.92
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol (1998) 2.60
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55
Imaging protein kinase Calpha activation in cells. Science (1999) 2.37
Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol (1999) 2.17
Biological activities of Brucella abortus lipopolysaccharides. Infect Immun (1981) 2.13
A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess (2013) 2.09
Nucleotide sequence of the 16S rRNA from Brucella abortus. Nucleic Acids Res (1989) 2.05
Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res (1999) 2.02
Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides. Infect Immun (1981) 1.96
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82
The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A (2002) 1.77
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74
[Validity of the protocol for evaluating the inappropriate use of hospitalization]. Med Clin (Barc) (1996) 1.70
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem (1992) 1.58
Monochromatic aberrations and point-spread functions of the human eye across the visual field. J Opt Soc Am A Opt Image Sci Vis (1998) 1.56
Xotch, the Xenopus homolog of Drosophila notch. Science (1990) 1.55
Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology (1999) 1.51
Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis. J Clin Microbiol (1980) 1.50
Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J Bacteriol (1996) 1.49
Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect (2006) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47
Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun (1984) 1.45
A new species of Leishmania parasite from the Venezuelan Andes region. Trans R Soc Trop Med Hyg (1979) 1.43
MR findings in primary antiphospholipid syndrome. AJNR Am J Neuroradiol (1991) 1.43
Characterization of Brucella abortus soluble antigen employed in immunoassay. J Clin Microbiol (1980) 1.43
The immune spectrum in patients with pulmonary tuberculosis. Am Rev Respir Dis (1981) 1.43
The Treatment of Acute Suppression of Urine by Incision and Drainage of the Kidneys. Proc R Soc Med (1911) 1.40
[Caroli disease: a case report and review of literature]. Acta Gastroenterol Latinoam (1998) 1.39
[Laparoscopic cholecystectomy without pneumoperitoneum. A review of 150 cases]. Acta Gastroenterol Latinoam (2000) 1.39
Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg (1996) 1.39
Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38
Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology (2008) 1.38
Half-life of the plasma membrane ATPase and its activating system in resting yeast cells. Biochim Biophys Acta (1991) 1.33
Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J Immunol (1979) 1.32
Mitochondrial DNA variation of Triatoma infestans populations and its implication on the specific status of T. melanosoma. Mem Inst Oswaldo Cruz (1999) 1.32
High dynamics of rDNA cluster location in kissing bug holocentric chromosomes (Triatominae, Heteroptera). Cytogenet Genome Res (2012) 1.31
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
Persistent Pain in Lesions of the Peripheral and Central Nervous System. Proc R Soc Med (1922) 1.29
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis (1993) 1.26
Cytogenetics and genome evolution in the subfamily Triatominae (Hemiptera, Reduviidae). Cytogenet Genome Res (2010) 1.24
Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol (2000) 1.24
Enzyme immunoassays for serological diagnosis of bovine brucellosis: A trial in Latin America. Clin Diagn Lab Immunol (1998) 1.23
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat (1984) 1.21
Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun (1992) 1.20
A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma (2000) 1.19
Transcriptional analysis of multigene family 110 of African swine fever virus. J Virol (1992) 1.19
Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17
An Escherichia coli protein consisting of a domain homologous to FK506-binding proteins (FKBP) and a new metal binding motif. J Biol Chem (1994) 1.16
Entanglement of two qubits mediated by one-dimensional plasmonic waveguides. Phys Rev Lett (2011) 1.15
Threshold-level repetitive transcranial electrical stimulation for intraoperative monitoring of central motor conduction. J Neurosurg (2001) 1.15
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol (1997) 1.13
Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol (1999) 1.12
Ciliary Neuralgia and its Treatment. Br Med J (1936) 1.12
Brucella lipopolysaccharides and polysaccharides. Ann Inst Pasteur Microbiol (1987) 1.11
Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect (2000) 1.11
DIFFERENTIAL RATES OF DEVELOPMENT OF HETEROTIC AND NONHETEROTIC YOUNG MAIZE SEEDLINGS, I. CORRELATION OF DIFFERENTIAL MORPHOLOGICAL DEVELOPMENT WITH PHYSIOLOGICAL DIFFERENCES IN GERMINATING SEEDS. Proc Natl Acad Sci U S A (1964) 1.10
Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun (1984) 1.10
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09
BB and pellet guns--toys or deadly weapons? J Trauma (1983) 1.09
New vaccines require potent adjuvants like AFPL1 and AFCo1. Scand J Immunol (2007) 1.07
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Med Clin (Barc) (1998) 1.07
Chromosomal variation and genome size support existence of cryptic species of Triatoma dimidiata with different epidemiological importance as Chagas disease vectors. Trop Med Int Health (2006) 1.06
Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J Immunol (1999) 1.05
The depth-of-field of the human eye from objective and subjective measurements. Vision Res (1999) 1.05
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem (1993) 1.05
Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol (2002) 1.05
Management of limb length inequality during total hip replacement. Clin Orthop Relat Res (1996) 1.04
Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry (2011) 1.04
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol (2005) 1.03
Diffuse optical tomography of pain and tactile stimulation: activation in cortical sensory and emotional systems. Neuroimage (2008) 1.03
Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol (1995) 1.01
An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol (2001) 1.01
Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae. Clin Diagn Lab Immunol (2001) 1.00
Images in cardiology: Right atrial lithomyxoma with extramedullary hematopoiesis. Heart (2002) 1.00
Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc (1995) 0.99
Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. Transplant Proc (1988) 0.99
Right-sided Extra-cerebellar Tumour. Proc R Soc Med (1908) 0.98
Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol (1995) 0.98
Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis (2001) 0.97
Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur J Biochem (1998) 0.96
Toxic effects of dissolved heavy metals on Desulfovibrio vulgaris and Desulfovibrio sp. strains. J Hazard Mater (2006) 0.96
Perception of random dot interference patterns. Nature (1973) 0.96
Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma (1998) 0.95
Inappropriate treatment in children with bloody diarrhea: clinical and microbiological studies. Arch Med Res (1995) 0.95
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J Pharmacol Exp Ther (1994) 0.94
Sex differences in the platelet response to aspirin. Thromb Res (1982) 0.94
Diaphragmatic or transdiaphragmatic thoracic involvement in hepatic hydatid disease: surgical trends and classification. World J Surg (1995) 0.94
BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. Gene Ther (2010) 0.94
Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis (2007) 0.94